A and -D are members of the collectin family of host defense proteins that share four distinct structural domains: NH 2-terminal oligomerization, collagenous, neck, and carbohydrate recognition (CRD). To determine the specificity of the functions of these domains, the SFTPC promoter was used to express 1) full-length rat (r) Sftpa; 2) NH 2- Previous studies in vivo demonstrated that SP-D functions in the regulation of surfactant lipids and prevention of emphysema is dependent on its NH 2 -terminal cysteine cross-linking domain (42). Substitution of the neck domain and CRD of SP-D with those of bovine conglutinin completely rescued viral clearance and cytokine production and partially rescued phospholipid abnormalities in Sftpd Ϫ/Ϫ mice (41). However, substitution of the NH 2 -terminal Cys-Cys cross-linking domain of SP-D in SP-A was not sufficient to correct the structural and lipid abnormalities in Sftpd Ϫ/Ϫ mouse lungs (26), indicating that the CRD or the collagen domain of SP-D was likely required for these activities. Because SP-A content is decreased in Sftpd Ϫ/Ϫ mice, it also remains unclear whether some or all of the abnormalities seen in Sftpd Ϫ/Ϫ mice are caused by changes in SP-A.
hydrate recognition domain (CRD) (13, 30) . The collectins are assembled as higher-ordered oligomers of trimeric subunits. SP-A is predominantly assembled as a bouquet of octadecamers consisting of six trimeric subunits. SP-D is predominantly assembled as dodecamers consisting of four trimeric subunits (8) . In the lung, SP-A and SP-D are both synthesized and secreted by type II cells and nonciliated bronchiolar epithelial cells (6, 7, 35) .
Previous studies of gene-targeted mice demonstrated that SP-A and SP-D have distinct roles in lung homeostasis. Lung morphology, SP-B, -C, and -D, lung tissue and alveolar phospholipid pool sizes, and lung compliance were not changed in Sftpa-null (Sftpa Ϫ/Ϫ ) mice (18) . Sftpd-null (Sftpd Ϫ/Ϫ ) mice develop pulmonary abnormalities including lipid accumulations, emphysema, as well as foamy macrophage and lymphocyte infiltration (2, 19) . The alveolar macrophages in Sftpd Ϫ/Ϫ mice have increased oxidant production and matrix metalloproteinase (MMP2, MMP9, and MMP12) activities that may contribute to the pulmonary abnormalities seen in this animal model (40) . Decreased concentration of SP-A was observed in the lung and bronchoalveolar lavage fluid (BALF) of Sftpd Ϫ/Ϫ mice (16) .
Previous studies in vivo demonstrated that SP-D functions in the regulation of surfactant lipids and prevention of emphysema is dependent on its NH 2 -terminal cysteine cross-linking domain (42) . Substitution of the neck domain and CRD of SP-D with those of bovine conglutinin completely rescued viral clearance and cytokine production and partially rescued phospholipid abnormalities in Sftpd Ϫ/Ϫ mice (41) . However, substitution of the NH 2 -terminal Cys-Cys cross-linking domain of SP-D in SP-A was not sufficient to correct the structural and lipid abnormalities in Sftpd Ϫ/Ϫ mouse lungs (26) , indicating that the CRD or the collagen domain of SP-D was likely required for these activities. Because SP-A content is decreased in Sftpd Ϫ/Ϫ mice, it also remains unclear whether some or all of the abnormalities seen in Sftpd Ϫ/Ϫ mice are caused by changes in SP-A.
To investigate whether the decrease in SP-A levels in Sftpd Ϫ/Ϫ mice contributes to the structural and lipid abnormalities in the lung, we introduced full-length rat (r) rSftpa into the lungs of Sftpd Ϫ/Ϫ mice. To investigate whether the neck domain and CRD of SP-A and SP-D are functionally inter-changeable, we expressed the fusion protein NH 2 -rSftpa/d consisting of NH 2 -terminal and collagenous domains of SP-A with neck domain and CRD of SP-D in Sftpd Ϫ/Ϫ mice. Neither the increased expression of SP-A nor the fusion protein NH 2 -rSftpa/d corrected the morphological and phospholipid abnormalities typical of Sftpd Ϫ/Ϫ mice. Our results indicated that SP-A and SP-D have distinct functions in lung homeostasis and that the function of the neck domain and CRD of SP-D is dependent on its own NH 2 -terminal and collagenous domains that cannot be complemented by those of SP-A. The NH 2 -terminal and collagenous domains determine the interaction of SP-D with lipids that is associated with the regulation of surfactant lipid pool sizes.
MATERIALS AND METHODS
Mouse husbandry. Mice used in experimental procedures were handled in accordance with approved protocols through the Institutional Animal Care and Use Committee at Cincinnati Children's Hospital. All mice had been maintained in the vivarium under barrier containment facilities. At the time of study, all mice appeared healthy with no evidence of infection. Sentinel mice in the colony were serologically negative for common murine pathogens.
Generation of transgenic mice. NH 2- Table 1 . Littermates were used for comparisons in each experiment to minimize differences related to strain.
Western blot analysis. Animals were weighed, anesthetized by intraperitoneal injection of pentobarbital, and exsanguinated by severing the distal aorta. Bronchoalveolar lavage (BAL) was performed five times with saline for each lung, and the collected volume was measured (18) . BALF (25 l) from each mouse was vacuum dried and reconstituted in 15 l of nonreduced or reduced (with ␤-mercaptoethanol) Laemmli sample buffer (Bio-Rad, Hercules, CA). After resolution with a 10 -20% SDS-Tris-glycine-polyacrylamide gel (Novex, San Diego, CA) and transfer to nitrocellulose membrane, blots were blocked with 5% nonfat milk and then incubated at room temperature (RT) overnight with either rabbit anti-mouse SP-D antibody (1:5,000) or guinea pig anti-rat SP-A antibody (1:10,000) in Tris-buffered saline (TBS) with 0.1% Tween 20. Blots were washed with TBS-Tween and incubated at RT for 4 h with 1:5,000 dilution of peroxidase-conjugated goat anti-rabbit IgG antibody or goat antiguinea pig IgG antibody (Calbiochem, La Jolla, CA). After washing, blots were developed with a chemiluminescence detection system (Amersham Pharmacia Biotech, Chalfont St. Giles, UK). Generally, four to eight mice from each genotype were analyzed for each mouse line, and representative results are shown.
Lung morphology. Mouse lungs (12 wk old) were fixed at 25-cmH 2O pressure with 4% paraformaldehyde in phosphate-buffered saline (PBS) and processed into paraffin blocks. Three to five mice from each genotype were analyzed for each experiment. Five-micrometer sections from each lobe were stained with hematoxylin and eosin. Immunostaining of endogenous SP-D and transgenic NH 2-rSftpa/d was performed in lung tissue with an avidin-biotin-peroxidase technique (Vectastain Elite ABC kit, Vector Laboratories). The rabbit anti-mouse SP-D antibody was generated against purified mouse SP-D and affinity absorbed against lung homogenates from Sftpd Ϫ/Ϫ mice (33) . Immunostaining of endogenous SP-A and transgenic rSP-A used rabbit anti-rat SP-A antibody as reported previously (10) .
Phospholipid analysis. BAL was performed on 8-wk old-mice by repeated installation of five aliquots of 1 ml of saline on each lung. After lavage, lung tissue was homogenized in saline. The amount of saturated phosphatidylcholine (Sat PC) in BALF and in the lung homogenate was measured as previously described (19) . Mice (7-10) from each genotype were analyzed, and the differences between genotypes were evaluated by ANOVA Fisher analysis. Differences of P Ͻ 0.05 were considered significant.
Ultrastructure of surfactant lipid aggregate. Large (LA)-and small (SA)-aggregate surfactant were isolated from pooled BALF samples (n ϭ 5) by sucrose gradient centrifugation as described previously (15) . Samples were processed for electron microscopy. Electron micrographs were randomly taken from ultrathin sections (90 nm).
Zymography assay for MMP2 and MMP9. BAL was performed in adult mice by instillation of 10 aliquots of 1 ml of PBS. Alveolar macrophages (5 ϫ 10 5 ) from each genotype were cultured in AIM-V medium (GIBCO, Carlsbad, CA) for 24 h in a 24-well plate at 37°C. Cultured media were concentrated with gelatin Sepharose 4B beads (Amersham Pharmacia Biotech) and suspended in 2ϫ Laemmli buffer without ␤-mercaptoethanol. After incubation at 37°C for 1 h, gelatin beads were loaded onto 10% zymogram gels (Invitrogen, Carlsbad, CA). The gels were renatured in 2.5% Triton X-100 at room temperature, incubated in developing buffer (Invitrogen) at 37°C overnight, and stained with 0.1% Coomassie blue at room temperature. After destaining with 7.5% acetic acid-5% methanol, MMP9 and MMP2 generated a clear band at 92 and 72 kDa, respectively.
RESULTS

Increased SP-A does not correct pulmonary abnormalities in Sftpd
Ϫ/Ϫ mice. Because SP-A levels are decreased in the lungs of Sftpd Ϫ/Ϫ mice (16), we determined whether increased expression of SP-A corrected pulmonary abnormalities in Sftpd Ϫ/Ϫ mice. Sftpd Ϫ/Ϫ mice were mated to mice that express increased levels of rSP-A in the airway (10) . SP-A levels in BALF were increased in rSftpa tgϩ 
/Sftpd
Ϫ/Ϫ compared with Sftpd Ϫ/Ϫ mice ( Fig. 1 ). In normal adult mice, SP-A staining was detected in type II alveolar epithelial cells, in macrophages, and in the bronchiolar epithelium ( Fig. 2A) . In Sftpd Ϫ/Ϫ mice ( Fig. 2E ), SP-A staining of type II alveolar and bronchiolar epithelial cells was de- (Fig. 4A, lanes  1 and 3) . After N-glycanase treatment, the proportion of the 34-kDa band was decreased and that of the 29-kDa band was increased (Fig. 4A, lanes 5-7) , indicating that the 34-kDa band was an N-glycosylated form of the NH 2 -rSftpa/d fusion protein. As expected, SP-D was not detected in the BALF of Sftpd Ϫ/Ϫ mice (Fig. 4A, lanes 2 and 4) . To determine whether the NH 2 -rSftpa/d fusion protein formed SP-A-or SP-D-like oligomers, BALF from NH 2 -rSftpa/d tgϩ /Sftpd Ϫ/Ϫ , Sftpd Ϫ/Ϫ , and WT mice were analyzed after separation in the absence of reducing agents. Rabbit anti-mouse SP-D antibody was used to detect the oligomerization of SP-D and NH 2 -rSftpa/d. Guinea pig anti-rat SP-A antibody was used to identify oligomers of SP-A. In the absence of reducing agent, SP-D and SP-A have distinct oligomerization patterns in WT mice (Fig. 4B, lanes 1 and 6) . SP-D forms oligomers of 2-, 3-, and 4-mers, whereas SP-A forms oligomers of 2-, 3-, 4-, 5-, and 6-mers. The NH 2 -rSftpa/d fusion protein oligomerized in a pattern similar to that of SP-A, with oligomers of 2-, 3-, 4-, 5-, and 6-mers (Fig. 4B, lanes  2-5) (Fig. 4C) , consistent with the distribution of SP-A rather than SP-D, suggesting that the oligomeric structure of the chimeric protein was determined by the collagenous and/or NH 2 (Fig. 6) . Thus the oligomeric structure, determined by the NH 2 -terminal and/or collagenous domain of SP-D is required for the regulation of surfactant lipids and suppression of lung inflammation.
Ultrastructure of surfactant lipids. Ultrastructures of LA and SA surfactant lipids were determined by electron microscopy (Fig. 7) . Abnormally large and dense lamellar bodies were observed in LA fraction from Sftpd Ϫ/Ϫ mice (Fig. 7G ) compared with WT mice (Fig. 7A) 
DISCUSSION
Although the domains shared by the pulmonary collectins SP-A and SP-D are structurally conserved, the functions of these proteins in the regulation of surfactant homeostasis are quite distinct. SP-A plays a critical role in the formation of tubulin myelin and host defense but does not regulate surfactant phospholipid pool sizes and is not required for surfactant function or maintenance of pulmonary homeostasis (18) . In contrast, SP-D is required for the regulation of surfactant pool sizes, the proportion of LA/SA surfactant lipids, the maintenance of alveolar structure, and the suppression of inflammation in the absence of infection or injury (19, 38) . Despite increased understanding of their structure and functions, the precise mechanisms and domains mediating the various activities of the pulmonary collectins remain poorly understood.
The present findings demonstrate that increased SP-A cannot compensate for SP-D-dependent pulmonary abnormalities. Expression of a chimeric NH 2 -rSftpa/d protein failed to rescue air space remodeling and lipid abnormalities in the Sftpd Ϫ/Ϫ mice, demonstrating that the activity of SP-D requires its collagenous and NH 2 -terminal regions, which cannot be replaced by those from SP-A. The pulmonary collectins play distinct roles in alveolar homeostasis that are determined by the integrated functions of both the NH 2 -and COOH-terminal regions of each molecule.
Increased SP-A fails to rescue Sftpd Ϫ/Ϫ dependent abnormalities. SP-A concentrations were decreased in BALF and lung tissue in the Sftpd Ϫ/Ϫ mice (16) . Increased expression of rSP-A in WT mice did not change the surfactant pool sizes, alveoli sizes, and surface activity of surfactant (10) . Expression of rSP-A in Sftpd Ϫ/Ϫ mice did not affect the alveolar and tissue Sat PC pool sizes, surfactant ultrastructure, alveolar macrophage infiltration, and air space abnormalities or suppress MMP activity. Thus decreased SP-A does not account for the pulmonary abnormalities in association with Sftpd deficiency. The findings that neither SP-A nor the chimeric NH 2 -rSftpa/d influenced the increased lipid pools in Sftpd Ϫ/Ϫ mice were consistent with previous findings in mice where the deletion of Sftpa or increased expression of Sftpa did not alter lung phospholipid pool sizes (10, 18) . Sat PC levels in both Sftpd Ϫ/Ϫ and WT mice are also influenced by genetic backgrounds, being higher in FVB/N background than in Swiss Black background (data not shown). In the present study, Sat PC levels in NH 2 30 Asn-Val-Thr (23, 29) . It is unclear whether this finding represents glycosylation that is normally present in the NH 2 -terminal region of rat SP-A or the domain is aberrantly glycosylated in the chimeric protein.
NH 2 -terminal domain of SP-D is required for correction of surfactant abnormalities.
SP-A partitioned with LA surfactant whereas SP-D partitioned with SA surfactant during fractionation by ultracentrifugation (15) . The lipid binding specificity of the collectins is thought to be mediated by the CRD (3, 9, 17, 24, 25, 28) . However, those studies assessed SP-D binding to isolated lipids bound to a solid phase rather than to lipid vesicles or surfactant particles. SP-D influences surfactant ultrastructure and regulates surfactant uptake by type II cells (15) . The lipid binding specificity of NH 2 -rSftpa/d is similar to that of SP-D in vitro (24) . A chimeric protein with the NH 2 -terminal and collagenous domains of SP-D linked to the neck and CRD domains of conglutinin partitioned with SA surfactant like SP-D and partially corrected lipid abnormalities in Sftpd Ϫ/Ϫ mice (41), raising the possibility that the SP-D CRD, or its specific lipid binding activity, may not be required in this activity. SP-D interacts selectively with SA surfactant in a process that influences surfactant uptake by type II cells (15) . The present study supports the concept that interaction with SA lipids is dependent on the NH 2 -terminal and collagenous domains of SP-D and cannot be substituted with those from SP-A. NH 2 -rSftpa/d protein did not correct the elevated Sat PC levels or the abnormal surfactant ultrastructure typical of Sftpd Ϫ/Ϫ mice. NH 2 -rSftpa/d also failed to correct foamy macrophage accumulation, peribronchiolar lymphocyte infiltrations, or development of air space abnormalities, indicating the requirement of the NH 2 -terminal and collagenous domains of SP-D for these activities. These results indicate that the function of rSP-D CRD requires the context of its own NH 2 -terminal and collagenous domains for full activity. Together, these data suggested a model in which oligomeric structures determined by the NH 2 -terminal and collagenous domains of SP-D play in important role in its interaction with surfactant lipid particles rather than a model dependent on lipid binding specificity conferred by the CRD.
NH 2 -rSftpa/d partially suppressed MMP expression but did not alter air space remodeling. Matrix metalloproteinases are a family of calcium-and zinc-dependent endopeptidases that play a key role in both normal and pathological processes involving tissue-remodeling events. MMP9 is normally expressed by a number of cell types including neutrophils, macrophages, osteoclasts, and trophoblasts. MMP9 cleaves extracellular matrix proteins (36, 37) . Increased expression of (20) . In human diseases such as asthma, chronic obstructive pulmonary disease, and emphysema, increased secretion of MMP9 and MMP12 are associated with the pathogenesis of the diseases (5). The mechanism of air space enlargement in Sftpd Ϫ/Ϫ mice is not obvious. Potential mechanisms might include epithelial damage from macrophagederived oxidants or impaired alveolar VEGF expression with associated alveolar epithelial apoptosis.
MMP9 modifies lymphocytic infiltration in Sftpd Ϫ/Ϫ mice. Sftpd Ϫ/Ϫ mice develop peribronchial and perivascular lymphocytic infiltration. FACS analysis showed that the relative distribution of lymphocyte classes (CD4 ϩ ,CD8 ϩ T cells, NK cells, or B cells) was not different in Sftpd Ϫ/Ϫ and WT mice. In Sftpd Ϫ/Ϫ mice, the CD4 ϩ ,CD8 ϩ lymphocytes were activated and an increase in memory CD4 ϩ lymphocytes was observed (11) . In Mmp9 Ϫ/Ϫ /Sftpd Ϫ/Ϫ double knockout mice lungs, lymphocytic infiltration was not observed, even though foamy macrophage infiltration and emphysema persisted, indicating that MMP9 is required for lymphocytic infiltration in Sftpd Ϫ/Ϫ mice. MMP9 has been shown to be critical for the release of kit-ligand to recruit stem and progenitor cells from the bone marrow niche (14) . However, in IL-13-induced inflammation, neutrophil infiltration was increased and lymphocyte infiltration persisted (20) . Thus the lymphocytic infiltration seen in Sftpd Ϫ/Ϫ mice is dependent on MMP9 and is distinct from that induced by IL-13.
Summary. The NH 2 -terminal and collagenous domains of SP-A were not sufficient to substitute for those of SP-D in vivo. The NH 2 -terminal domains of SP-D determine its oligomerization state and its association with SA rather than LA surfactant lipids. Increased SP-A or an NH 2 -rSftpa/d fusion protein did not restore surfactant homeostasis or protect from air space remodeling in Sftpd Ϫ/Ϫ mice, indicating that the CRD of SP-D requires its NH 2 -terminal and collagenous domains for its full biological function. At present, analysis of various chimeric and mutated SP-D proteins (see Table 2 ) supports the concept that the NH 2 -terminal and collagenous domains of SP-D play important roles in surfactant structure and metabolism. The findings that the CRD of conglutinin partially restored surfactant homeostasis when linked to the NH 2 -terminal and collagenous domains of SP-D suggest that the specific interactions of the SP-D CRD with surfactant lipids are not required for its influence on surfactant homeostasis and that the NH 2 -terminal and collagenous domains of SP-D play an important role in the interaction of SP-D with surfactant lipid particles. The ability of SP-D to regulate surfactant homeostasis may not rely on its interaction with specific phospholipids, but rather on its interaction with small aggregate surfactant.
